Abstract
Morbidly obese individuals often require surgery, including bariatric (weight management) surgery. Acute pain management in the morbidly obese must consider the risk of chronic post-surgical pain, opioid dependence, and comorbidities (e.g. sleep-disordered breathing). A stepped, multimodal, opioid-sparing approach titrated to the type and severity of pain type should be taken, with co-administration of systemic and local anaesthetic agents when appropriate.
Similar content being viewed by others
References
Nightingale CE, Margarson MP, Shearer E, et al. Peri-operative management of the obese surgical patient 2015: Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Bariatric Anaesthesia. Anaesthesia. 2015;70:859–76.
Belcaid I, Eipe N. Perioperative pain management in morbid obesity. Drugs. 2019;79(11):1163–75.
Thorell A, MacCormick AD, Awad S, et al. Guidelines for perioperative care in bariatric surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations. World J Surg. 2016;40:2065–83.
Zeidan A, Al-Temyatt S, Mowafi H, et al. Gender-related difference in postoperative pain after laparoscopic Roux-En-Y gastric bypass in morbidly obese patients. Obes Surg. 2013;23:1880–4.
Chung F, Yang Y, Liao P. Predictive performance of the STOPBANG score for identifying obstructive sleep apnea in obese patients. Obes Surg. 2013;23:2050–7.
Raebel MA, Newcomer SR, Reifler LM, et al. Chronic use of opioid medications before and after bariatric surgery. JAMA. 2013;310:1369–76.
Weingarten TN, Sprung J, Flores A, et al. Opioid requirements after laparoscopic bariatric surgery. Obes Surg. 2011;21:1407–12.
Liu SS, Buvanendran A, Rathmell JP, et al. Predictors for moderate to severe acute postoperative pain after total hip and knee replacement. Int Orthop. 2012;36:2261–7.
Mei W, Seeling M, Franck M, et al. Independent risk factors for postoperative pain in need of intervention nearly after awakening from general anaesthesia. Eur J Pain. 2010;14(2):149.e1–e7.
Yen CR, Tsou MY, Mandell MS, et al. An analysis of patient variables that influence intravenous patient-controlled analgesic use of morphine with quantile regression. Anesthesiology. 2010;112:688–95.
Ingrande J, Lemmens HJM. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010;105:16–23.
Budiansky AS, Margarson MP, Eipe N. Acute pain management in morbid obesity: an evidence based clinical update. Surg Obes Rel Dis. 2017;13:523–32.
Bidgoli J, Delesalle S, De Hert SG, et al. A randomised trial comparing sufentanil versus remifentanil for laparoscopic gastroplasty in the morbidly obese patient. Eur J Anaesthesiol. 2011;28:120–4.
Ziemann-Gimmel P, Hensel P, Koppman J, et al. Multimodal analgesia reduces narcotic requirements and antiemetic rescue medication in laparoscopic Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2013;9:975–80.
Zhang J, Ding EL, Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA. 2006;296:1619–32.
Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769–79.
Murphy JD, Yan D, Hanna MN, et al. Comparison of the postoperative analgesic efficacy of intravenous patient-controlled analgesia with tramadol to intravenous patient-controlled analgesia with opioids. J Opioid Manag. 2010;6:141–7.
Hollingshead J, Duhmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2006;3:CD003726.
Nehoda H, Lanthaler M, Labeck B, et al. A study of pain after laparoscopic gastric banding. Obes Surg. 2001;11:208–11.
Ng JJ, Leong WQ, Tan CS, et al. A multimodal analgesic protocol reduces opioid-related adverse events and improves patient outcomes in laparoscopic sleeve gastrectomy. Obes Surg. 2017;27:3075–81.
Lam KKY, Mui WLM. Multimodal analgesia model to achieve low postoperative opioid requirement following bariatric surgery. Hong Kong Med J. 2016;22(22):428–34.
Ultram® (tramadol hydrochloride) tablets: US prescribing information. Titusville (NJ): Janssen Pharmaceuticals, Inc.; 2019.
Bamgbade OA, Oluwole O, Khaw RR. Perioperative analgesia for fast-track laparoscopic bariatric surgery. Obes Surg. 2017;27:1828–34.
Stamer UM, Lehnen K, Hothker F, et al. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain. 2003;105:231–8.
Avila C, Holloway A, Hahn M, et al. An overview of links between obesity and mental health. Curr Obes Rep. 2015;4:303–10.
Ahmad S, Nagle A, McCarthy RJ, et al. Postoperative hypoxemia in morbidly obese patients with and without obstructive sleep apnea undergoing laparoscopic bariatric surgery. Anesth Analg. 2008;107:138–43.
Tawfic QA. A review of the use of ketamine in pain management. J Opioid Manag. 2013;9:379–88.
Kamal HM. Ketamine as an adjuvant to morphine for patient controlled analgesia in morbidly obese patients. J Med Sci. 2008;8:364–70.
Chaparro LE, Smith SA, Moore RA, et al. Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev. 2013;7:CD008307.
Mathews TJ, Churchhouse AM, Housden T, et al. Does adding ketamine to morphine patient-controlled analgesia safely improve post-thoracotomy pain? Interact Cardiovasc Thorac Surg. 2012;14:194–9.
Hasanein R, El-Sayed W, Nashwa N, et al. The effect of combined remifentanil and low dose ketamine infusion in patients undergoing laparoscopic gastric bypass. Egypt J Anaesthesiol. 2011;27:255–60.
Feld JM, Laurito CE, Beckerman M, et al. Non-opioid analgesia improves pain relief and decreases sedation after gastric bypass surgery. Can J Anaesth. 2003;50:336–41.
Sollazzi L, Modesti C, Vitale F, et al. Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery. Surg Obes Relat Dis. 2009;5:67–71.
Hassani V, Pazouki A, Nikoubakht N, et al. The effect of gabapentin on reducing pain after laparoscopic gastric bypass surgery in patients with morbid obesity: a randomized clinical trial. Anesth Pain Med. 2015;5:e22372.
Hilvering B, Draaisma WA, van der Bilt JD, et al. Randomized clinical trial of combined preincisional infiltration and intraperitoneal instillation of levobupivacaine for postoperative pain after laparoscopic cholecystectomy. Br J Surg. 2011;98:784–9.
Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36.
DeBaerdemaeker LE, Jacobs S, Pattyn P, et al. Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity. Br J Anaesth. 2007;99:404–11.
Gaszynski TM, Strzelczyk JM, Gaszynski WP. Post-anesthesia recovery after infusion of propofol with remifentanil or alfentanil or fentanyl in morbidly obese patients. Obes Surg. 2004;14:498–503.
Machado FC, Palmeira CCDA, Torres JNL, et al. Intraoperative use of methadone improves control of postoperative pain in morbidly obese patients: a randomized controlled study. J Pain Res. 2018;11:2123–9.
De Oliveira GS, Duncan K, Fitzgerald P, et al. Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial. Obes Surg. 2014;24:212–8.
Blaudszun G, Lysakowski C, Elia N, et al. Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2012;116:1312–22.
Singh PM, Panwar R, Borle A, et al. Perioperative analgesic profile of dexmedetomidine infusions in morbidly obese undergoing bariatric surgery: a meta-analysis and trial sequential analysis. Surg Obes Relat Dis. 2017;13:1434–46.
Vigneault L, Turgeon AF, Cote D, et al. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth. 2011;58:22–37.
Sun Y, Li T, Wang N, et al. Perioperative systemic lidocaine for postoperative analgesia and recovery after abdominal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum. 2012;55:1183–94.
Dholakia C, Beverstein G, Garren M, et al. The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. J Gastrointest Surg. 2007;11:1556–9.
Raffa RB, Buschmann H, Christoph T, et al. Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother. 2012;13:1437–49.
Schumann R. Anaesthesia for bariatric surgery. Best Pract Res Clin Anaesthesiol. 2011;25:83–93.
Author information
Authors and Affiliations
Consortia
Ethics declarations
Conflict of interest
The article was adapted from Drugs 2019;79(11):1163-75 [2] by employees of Adis International Ltd./Springer Nature, who are responsible for the article content and declare no conflicts of interest.
Funding
The preparation of this review was not supported by any external funding.
Rights and permissions
About this article
Cite this article
Adis Medical Writers. Manage perioperative pain in morbidly obese patients by taking an all-round multimodal approach. Drugs Ther Perspect 36, 139–145 (2020). https://doi.org/10.1007/s40267-020-00705-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-020-00705-1